ImmunityBio, Inc. (FRA:26CA)
1.964
+0.104 (5.59%)
At close: Dec 4, 2025
-54.72% (1Y)
| Market Cap | 1.94B |
| Revenue (ttm) | 70.36M |
| Net Income (ttm) | -297.13M |
| Shares Out | n/a |
| EPS (ttm) | -0.35 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 653 |
| Open | 1.865 |
| Previous Close | 1.860 |
| Day's Range | 1.865 - 1.972 |
| 52-Week Range | 1.630 - 4.670 |
| Beta | n/a |
| RSI | 53.23 |
| Earnings Date | Mar 2, 2026 |